Skip to main content
Search RSC
Clinical Research Sites
Summary of Resources
Safety
Protocol Registration
Personnel Information
Protocol Information in DAIDS-ES
DAIDS Record Storage Assessment
DAIDS Financial Disclosure Forms
Informed Consent Process Information
Network & Protocol Teams
DAIDS Drug Risk Lists
Developing Protocols
Protocol Templates
Submit a Protocol
ClinicalTrials.gov
DAIDS Protocol Risk Worksheet
Trial Master File
Clinical Trials Insurance
Useful Links
DAIDS Staff
Resources
About Us
About DAIDS & RSC
News & Updates
FAQs
Events
Contact Us
Hide Filters
Filter Search Results
Filter by resource type:
(-)
Investigator Brochures
(82)
Filter by topic:
Safety and Adverse Events
(31)
Resources
Search for resources containing:
Your selections:
Clear all
Show Filters
We found
82 resources
that match your search.
Doravirine (MK-1439)
Document Date:
2021
Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A)
Document Date:
2021
Emtricitabine/Tenofovir Disoproxil Fumarate (Truvada) - Investigator's Brochure
Document Date:
2017
EnvSeq-1 and EnvSeq-2
Document Date:
2022
EnvSeq-1 Vaccine (CH505TF gp120)
Document Date:
2020
Etravirine (TMC125, Intelence) Investigator Brochure
Document Date:
2019
GLA-SE
Document Date:
2023
GS-2872 (10-1074 LS)
Document Date:
2025
GS-5423 (3BNC117-LS)
Document Date:
2025
GSK1265744 (Cabotegravir)
Document Date:
2025
HEC Placebo Gel
HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL)
Document Date:
2024
HIV-1 Vaccines AdC6-HIVgp140, AdC7-HIVgp140, CH505TF/GLA-SE
Document Date:
2021
HxB2.WT.Core-C4b, Adjuvanted
Document Date:
2024
ID93 + GLA Adjuvant Formulation Vaccine
Document Date:
2025
IHV01
Document Date:
2019
INO-6160 and INO-6172
Document Date:
2024
mRNA-1574 Trimer Vaccines
Document Date:
2025
mRNA-1645-eODGT8 and mRNA-1645-CoreG28v2
Document Date:
2024
mRNA-1645-N332GT5
Document Date:
2024
MTBVAC (New Generation Live-Attenuated Tuberculosis Vaccine)
Document Date:
2024
MVA-CMDR
Document Date:
2020
MVA.tHIVconsv3 Vaccine
Document Date:
2024
MVA.tHIVconsv4 Vaccine
Document Date:
2024
N-803
Document Date:
2024
Pagination
First page
« First
Previous page
‹‹
Page
1
Current page
2
Page
3
Page
4
Next page
››
Last page
Last »